曲美他嗪对高血压性心脏病患者心肌重构和氧化应激水平的影响(4)
参考文献
[ 1 ] HORGAN SJ, WATSON CJ, GLEZEVA N, et al. Serum amyloid P-component prevents cardiac remodeling in hypertensive heart disease[J]. J Cardiovasc Transl Res,2015,8(9):554-566.
[ 2 ] 张红明,李艳敏.微小RNA在心肌重构及心力衰竭中的作用[J].中华心血管病杂志,2014,42(12):1057-1061.
[ 3 ] 王超凡,徐亚伟.肥大细胞在慢性心力衰竭进展中的作用[J].上海医学,2012,35(9):812-815.
[ 4 ] STADNIK M, HANDZLIK-ORLIK G, SARNECKI K, et al. Clinical aspects of the use of trimetazidine in the prevention and treatment of myocardial diseases[J]. Przegl Lek,2013,70(9):730-734.
, http://www.100md.com
[ 5 ] ZHOU X, LI C, XU W, et al. Trimetazidine protects ag- ainst smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation[J]. PLoS One,2012,7(7):e40424.
[ 6 ] GAO D, NING N, NIU X, et al. Trimetazidine: a me- taanalysis of randomised controlled trials in heart failure[J]. Heart,2011,97(4):278-286.
[ 7 ] 熊燕,趙毅,顾少华,等.曲美他嗪治疗尿毒症性心肌病30例[J].实用医学杂志,2014,30(4):620-622.
, 百拇医药
[ 8 ] 中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志,2011,3(5):701-708.
[ 9 ] 葛均波,徐永健.内科学[M]. 8版.北京:人民卫生出版社,2013:163.
[10] 刘明波,李镒冲,刘世炜,等. 2010年中国人群高血压疾病负担[J].中华流行病学杂志,2014,35(6):680-683.
[11] 汪荣荣,蒋延波,薛枫.高血压心脏病的超声心动图诊断[J].浙江医学,2014,36(6):528-529.
[12] 王学夫,龙登毅.高血压主要并发症的药物治疗方案选择[J].中国药房,2008,19(26):2069-2071.
[13] YISIREYILI M, SHIMIZU H, SAITO S,et al.Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats[J]. Life Sci,2013,92(24/25/26):1180-1185.
, 百拇医药
[14] VERECKEI A. The role of oxidative stress in amiodaron toxicity, in left ventricular dysfunction of hypertensive patients and in heart failure with preserved ejection fraction[J]. Orv Hetil,2015,156(47):1921-1925.
[15] SINHA N, DABLA PK.Oxidative stress and antioxidants in hypertension-a current review[J]. Curr Hypertens Rev, 2015,11(2):132-142.
[16] MONTEZANO AC, DULAK-LIS M, TSIROPOULOU S, et al. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies[J]. Can J Cardiol,2015,31(5):631-641.
, 百拇医药
[17] BRITO R, CASTILLO G, GONZ?LEZ J,et al. Oxidative stress in hypertension: mechanisms and therapeutic opportunities[J]. Exp Clin Endocr Diab,2015,123(6):325-335.
[18] HOEY ET, PAKALA V, TEOH JK, et al. The role of imaging in hypertensive heart disease[J]. Int J Angiol,2014,23(2):85-92.
[19] 廖小龙,王首红,王中华,等.辛伐他汀对老年小鼠心肌缺血再灌注时氧化应激及细胞凋亡的影响[J].中国药房,2016,27(19):39-42.
(收稿日期:2017-04-19 修回日期:2017-11-17)
(编辑:林 静), 百拇医药(武文君 宣玲 汪朝晖 王廷涛 高兰兰 沙莎)
[ 1 ] HORGAN SJ, WATSON CJ, GLEZEVA N, et al. Serum amyloid P-component prevents cardiac remodeling in hypertensive heart disease[J]. J Cardiovasc Transl Res,2015,8(9):554-566.
[ 2 ] 张红明,李艳敏.微小RNA在心肌重构及心力衰竭中的作用[J].中华心血管病杂志,2014,42(12):1057-1061.
[ 3 ] 王超凡,徐亚伟.肥大细胞在慢性心力衰竭进展中的作用[J].上海医学,2012,35(9):812-815.
[ 4 ] STADNIK M, HANDZLIK-ORLIK G, SARNECKI K, et al. Clinical aspects of the use of trimetazidine in the prevention and treatment of myocardial diseases[J]. Przegl Lek,2013,70(9):730-734.
, http://www.100md.com
[ 5 ] ZHOU X, LI C, XU W, et al. Trimetazidine protects ag- ainst smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation[J]. PLoS One,2012,7(7):e40424.
[ 6 ] GAO D, NING N, NIU X, et al. Trimetazidine: a me- taanalysis of randomised controlled trials in heart failure[J]. Heart,2011,97(4):278-286.
[ 7 ] 熊燕,趙毅,顾少华,等.曲美他嗪治疗尿毒症性心肌病30例[J].实用医学杂志,2014,30(4):620-622.
, 百拇医药
[ 8 ] 中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志,2011,3(5):701-708.
[ 9 ] 葛均波,徐永健.内科学[M]. 8版.北京:人民卫生出版社,2013:163.
[10] 刘明波,李镒冲,刘世炜,等. 2010年中国人群高血压疾病负担[J].中华流行病学杂志,2014,35(6):680-683.
[11] 汪荣荣,蒋延波,薛枫.高血压心脏病的超声心动图诊断[J].浙江医学,2014,36(6):528-529.
[12] 王学夫,龙登毅.高血压主要并发症的药物治疗方案选择[J].中国药房,2008,19(26):2069-2071.
[13] YISIREYILI M, SHIMIZU H, SAITO S,et al.Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats[J]. Life Sci,2013,92(24/25/26):1180-1185.
, 百拇医药
[14] VERECKEI A. The role of oxidative stress in amiodaron toxicity, in left ventricular dysfunction of hypertensive patients and in heart failure with preserved ejection fraction[J]. Orv Hetil,2015,156(47):1921-1925.
[15] SINHA N, DABLA PK.Oxidative stress and antioxidants in hypertension-a current review[J]. Curr Hypertens Rev, 2015,11(2):132-142.
[16] MONTEZANO AC, DULAK-LIS M, TSIROPOULOU S, et al. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies[J]. Can J Cardiol,2015,31(5):631-641.
, 百拇医药
[17] BRITO R, CASTILLO G, GONZ?LEZ J,et al. Oxidative stress in hypertension: mechanisms and therapeutic opportunities[J]. Exp Clin Endocr Diab,2015,123(6):325-335.
[18] HOEY ET, PAKALA V, TEOH JK, et al. The role of imaging in hypertensive heart disease[J]. Int J Angiol,2014,23(2):85-92.
[19] 廖小龙,王首红,王中华,等.辛伐他汀对老年小鼠心肌缺血再灌注时氧化应激及细胞凋亡的影响[J].中国药房,2016,27(19):39-42.
(收稿日期:2017-04-19 修回日期:2017-11-17)
(编辑:林 静), 百拇医药(武文君 宣玲 汪朝晖 王廷涛 高兰兰 沙莎)